Nagoya, Japan

Kazuo Kato

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1981-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuo Kato: Innovator in Pharmaceutical Compounds

Introduction

Kazuo Kato is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds that exhibit various therapeutic activities. With a total of 2 patents, Kato's work has the potential to impact medical treatments significantly.

Latest Patents

Kato's latest patents include two important pharmaceutical compounds. The first is a flavan compound, which is represented by a specific formula. This compound, along with its pharmaceutically acceptable acid addition salts, is recognized for its anti-convulsive, anti-ulcer, anti-arrhythmic, and diuretic activities. The second patent involves 1,5-benzothiazepine compounds, which can be either cis or trans forms. These compounds are also represented by a specific formula and are known for their anticholinergic activity. They are useful as anti-ulcer agents, gastric secretion inhibitors, and antispasmodic agents in mammals.

Career Highlights

Kazuo Kato is associated with Maruko Seiyaku Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to advancing medical science through the creation of effective compounds.

Collaborations

Kato has collaborated with notable coworkers, including Sachio Ohno and Mitsuaki Nagasaka. Their combined expertise contributes to the innovative environment at Maruko Seiyaku Co., Ltd.

Conclusion

Kazuo Kato's contributions to pharmaceutical innovations through his patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…